These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8438493

  • 1. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
    [No Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
    Paul LC, Davidoff A, Paul DW, Benediktsson H, Issekutz TB.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
    [No Abstract] [Full Text] [Related]

  • 3. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 4. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM, Tu Y, Condon TP, Bennett CF.
    Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
    [No Abstract] [Full Text] [Related]

  • 5. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
    Harihara Y, Sugawara Y, Inoue K, Kubota K, Bandai Y, Makuuchi M, Miyasaka M.
    Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698
    [No Abstract] [Full Text] [Related]

  • 6. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA.
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [Abstract] [Full Text] [Related]

  • 7. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
    Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ.
    Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
    [No Abstract] [Full Text] [Related]

  • 8. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M, Ihara A.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract] [Full Text] [Related]

  • 10. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
    Miwa S, Kawasaki S, Makuuchi M, Miyasaka M, Yamazaki S, Sekiguchi M, Isobe M.
    Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD, Schachner RS, Kong SS, Qian T, Alejandro R, Mintz DH.
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract] [Full Text] [Related]

  • 12. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 13. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC, Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J, Isobe M, Yamazaki S, Horie S, Okubo Y, Sekiguchi M.
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [Abstract] [Full Text] [Related]

  • 15. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE.
    Transplantation; 1993 Feb; 55(2):412-7. PubMed ID: 8094583
    [No Abstract] [Full Text] [Related]

  • 16. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A, Nagata M, Ochiai T, Nakajima K, Hori S, Asano T, Isono K, Tamatani T, Miyasaka M.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract] [Full Text] [Related]

  • 17. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M.
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract] [Full Text] [Related]

  • 18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y, Tang XD, Zhou PJ.
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [Abstract] [Full Text] [Related]

  • 19. A single administration of LFA-1 antibody confers prolonged allograft survival.
    Talento A, Nguyen M, Blake T, Sirotina A, Fioravanti C, Burkholder D, Gibson R, Sigal NH, Springer MS, Koo GC.
    Transplantation; 1993 Feb; 55(2):418-22. PubMed ID: 7679531
    [Abstract] [Full Text] [Related]

  • 20. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.